A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

NCT04683406 PHASE3 COMPLETED

This is a multi-center, randomized, double-blind, placebo-controlled, and active controlled clinical trial to assess the efficacy and safety of ZSP1273 tablets in the treatment of Acute Uncomplicated influenza A.

Details

Lead sponsor	Guangdong Raynovent Biotech Co., Ltd
Phase	PHASE3
Status	COMPLETED
Enrolment	750
Start date	Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Influenza A

Interventions

• ZSP1273 600 mg
• Placebo to Oseltamivir
• Oseltamivir(oral)
• Placebo to ZSP1273

Countries

China